Combined use of deproteinized bovine bone mineral and α-tricalcium phosphate using gelatin carriers
Open Access
- 21 February 2025
- journal article
- research article
- Published by Springer Nature in BMC Oral Health
- Vol. 25 (1) , 1-12
Abstract
To study the effect on biomaterial degradation and bone formation of different ratios between α-tricalcium phosphate (α-TCP) and deproteinized bovine bone mineral (DBBM) using various gelatins as a carrier. Thirty-six critical-sized calvarial bone defects were randomly treated in 18 animals. Four biomaterials with different compositional relations of DBBM to α-TCP and granules to carrier were investigated: (1) 40 ± 10% DBBM/40 ± 10% α-TCP with 20 ± 10% gelatin type 1 in ratio 4:1 (B1/G1), (2) 20 ± 10% DBBM/60 ± 10% α-TCP with 20 ± 10% gelatin type 1 in ratio 4:1 (B2/G1), (3) 20 ± 10% DBBM/60 ± 10% α-TCP with 15 ± 10%/5 ± 5% gelatin type 2/ glycerine (B2/G2) and 4), 10 ± 10% DBBM/60 ± 10% α-TCP with 20 ± 10%/10 ± 10% gelatin type 2/ glycerine (B3/G2). As a positive control 50 ± 10% DBBM/50 ± 10% α-TCP without gelatin (PC, B1/G0) and as a negative control (NC) empty defects were chosen. All defects were covered with a collagen membrane. The samples were harvested 4 weeks post-surgically and examined by micro-CT and histomorphometric analysis. New bone formation was evident in all defects. The mineralized tissue volume was significantly higher in the four tested biomaterials than in the NC group, but lower compared to the PC group. Histomorphometry showed similar levels of bone formation in all groups, whereas only the PC group reached a significantly higher total augmentation area than that of the NC. The PC group showed significantly higher mineralized tissue density and residual material area compared to the B3/G2 group, and more residual DBBM than the four tested biomaterials. New bone formation was not significantly affected either by different DBBM:α-TCP compositional ratios nor the presence of various gelatin carriers. Similar levels of osteoconductivity indicates the presumptive use of combined products in alveolar ridge augmentation to support bone formation. Gelatin with or without glycerine may be considered for its use as a carrier to the biomaterials frequently applied in peri-implant surgery.Keywords
This publication has 28 references indexed in Scilit:
- Alveolar ridge dimensional changes after two socket sealing techniques. A pilot randomized clinical trialClinical Oral Investigations, 2020
- Improved physical and osteoinductive properties of demineralized bone matrix by gelatin methacryloyl formulationJournal of Tissue Engineering and Regenerative Medicine, 2020
- Chitosan and gelatin-based electrospun fibers for bone tissue engineeringInternational Journal of Biological Macromolecules, 2019
- Biomimetic composite scaffolds containing bioceramics and collagen/gelatin for bone tissue engineering - A mini reviewInternational Journal of Biological Macromolecules, 2016
- Irradiation Sterilized Gelatin–Water–Glycerol Ternary Gel as an Injectable Carrier for Bone Tissue EngineeringAdvanced Healthcare Materials, 2016
- Comparative study of biphasic calcium phosphate with beta-tricalcium phosphate in rat cranial defects—A molecular-biological and histological studyAnnals of Anatomy - Anatomischer Anzeiger, 2015
- Bone healing around nanocrystalline hydroxyapatite, deproteinized bovine bone mineral, biphasic calcium phosphate, and autogenous bone in mandibular bone defectsJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2014
- Ceramic and non-ceramic hydroxyapatite as a bone graft material: a brief reviewIrish Journal of Medical Science (1971 -), 2014
- α-Tricalcium phosphate: Synthesis, properties and biomedical applicationsActa Biomaterialia, 2011
- Deproteinized bovine bone in periodontal and implant surgeryDental Materials, 2011